Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-25 @ 5:11 AM
NCT ID:
NCT05890027
Eligibility Criteria:
Inclusion Criteria:
* Individuals diagnosed with ptosis undergoing conjunctival Muller's muscle resection evaluation.
* Individuals who can tolerate and have no hypersensitivity to phenylephrine 2.5% ophthalmic solution.
* Individuals who can tolerate eye-drop medications.
* Individuals who are physically able to take a tangent screen visual field test.
* Age: Adults who can comprehend the instructions and procedures (18+ years old)
Exclusion Criteria:
\- This study will not incorporate any of the following at-risk populations: adults unable to consent, individuals who are not yet adults, pregnant women, prisoners.
* This study will not include participants who refuse to consent.
* This study will not include participants who are too tired or unable to take a tangent screen visual field test (see Risk to Subjects).
* This study will not include individuals who may not be able to tolerate phenylephrine 2.5% ophthalmic solution.
* Specifically, those with a past medical history of bradycardia, hypotension, autonomic dysfunction, or severe cardiovascular disease
* This study will not include individuals who consume drugs contraindicated in phenylephrine use: Ergot Derivatives (Vasoconstrictive CYP3A4 Substrates), Iobenguane Radiopharmaceutical Products, Kratom, Lisuride, Monoamine Oxidase Inhibitors
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05890027
Study Brief:
Protocol Section:
NCT05890027